Newell, P., Toffanin, S., Villanueva, A., Chiang, D. Y., Minguez, B., Cabellos, L., . . . Llovet, J. M. (2009). Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
Citação norma ChicagoNewell, Pippa, et al. Ras Pathway Activation in Hepatocellular Carcinoma and Anti-tumoral Effect of Combined Sorafenib and Rapamycin in Vivo. 2009.
MLA citiranjeNewell, Pippa, et al. Ras Pathway Activation in Hepatocellular Carcinoma and Anti-tumoral Effect of Combined Sorafenib and Rapamycin in Vivo. 2009.
Opozorilo: Ti citati niso vedno 100% točni.